Boston An independent LDT provider

Press releases

September 7, 2017 | REGULATORY

Immunovia announces collaboration with Lund University Diabetes Centre for the early detection of pancreatic cancer in diabetes risk group

Read press release
August 23, 2017 | REGULATORY

Immunovia Interim report, January-June 2017

Read press release
August 18, 2017

Immunovia invites to a conference call on August 23, 2017

Read press release
July 17, 2017 | REGULATORY

Leading expert on pancreatic cancer, Professor Stephen Pereira at University College London, joins Immunovia’s Scientific Advisory Board

Read press release
June 30, 2017 | REGULATORY

Immunovia together with Oregon Health and Science University awarded one of the Pancreatic Cancer Action Network 2017 Research Grants

Read press release
June 28, 2017 | REGULATORY

Immunovia establishes US headquarters, including CLIA reference laboratory, in Boston

Read press release
June 21, 2017 | REGULATORY

Immunovia’s IMMray™ presents biomarkers that differentiates Rheumatoid Arthritis from other autoimmune diseases with 89% accuracy

Read press release
June 16, 2017 | REGULATORY

Immunovia AB announces timetable for listing on Nasdaq Stockholm’s main market

Read press release
June 13, 2017 | REGULATORY

Immunovia´s biomarker signature for the diagnosis of pancreatic cancer now patented in Japan

Read press release
April 25, 2017 | REGULATORY

Immunovia Stämmokommuniké

Read press release
April 20, 2017 | REGULATORY

Immunovia Interim report, January-March 2017

Read press release
April 19, 2017

Immunovia inbjuder till telefonkonferens den 20 april 2017

Read press release
1 24 25 26 27 28 31